3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
51
Terminated
13
Unknown
7
Recruiting
7
Active not recruiting
4
Not yet recruiting
2
No longer available
2
Withdrawn
1
Suspended
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Neoplasms
19
Prostatic Neoplasms
9
Breast Neoplasms
9
Melanoma
8
Colorectal Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Pancreatic Neoplasms
6
Neoplasm Metastasis
6
Ovarian Neoplasms
5
Carcinoma, Hepatocellular
5
Triple Negative Breast Neoplasms
4
Solid Tumors
4
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Glioblastoma
4
Carcinoma, Renal Cell
4
Stomach Neoplasms
3
Multiple Myeloma
3
Lymphoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia
3
Uterine Cervical Neoplasms
2
Small Cell Lung Carcinoma
2
Sarcoma
2
Recurrence
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pain
2
Mesothelioma
2
Lymphoma, T-Cell
2
Liver Neoplasms
2
Interventions
Drug Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
INDUSTRY
×
Lymphoma, T-Cell, Cutaneous
×
Clear all
NCT05138458
2023-11-13
IMAGINE
Myeloid Therapeutics
Phase 1/2
Suspended
40 enrolled